Fatty Acid Synthase Confers Tamoxifen Resistance to ER+/HER2+ Breast Cancer

SIMPLE SUMMARY: Overactivation of the human epidermal growth factor receptor 2 (HER2) is one of the main drivers of tamoxifen resistance in estrogen receptor (ER)-positive breast cancer patients. Combined targeting of HER2 and ER, however, has yielded disappointing results in the clinical setting. T...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cancers (Basel)
Päätekijät: Menendez, Javier A., Papadimitropoulou, Adriana, Vander Steen, Travis, Cuyàs, Elisabet, Oza-Gajera, Bharvi P., Verdura, Sara, Espinoza, Ingrid, Vellon, Luciano, Mehmi, Inderjit, Lupu, Ruth
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: MDPI 2021
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7961649/
https://ncbi.nlm.nih.gov/pubmed/33800852
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13051132
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia